{
  "actions": [
    {
      "acted_at": "2021-12-16",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-12-16",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [
        {
          "reference": "CR S9263-9264",
          "type": "Sponsor introductory remarks on measure"
        }
      ],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s3427-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "117",
  "cosponsors": [
    {
      "bioguide_id": "L000570",
      "district": null,
      "name": "Lujan, Ben Ray",
      "original_cosponsor": true,
      "sponsored_at": "2021-12-16",
      "state": "NM",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-12-16",
  "number": "3427",
  "official_title": "A bill to authorize the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Neuroscience Center of Excellence Act of 2021",
  "sponsor": {
    "bioguide_id": "C001035",
    "district": null,
    "name": "Collins, Susan M.",
    "state": "ME",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-12-16",
  "subjects": [
    "Cancer",
    "Cardiovascular and respiratory health",
    "Congressional oversight",
    "Department of Health and Human Services",
    "Digital media",
    "Drug safety, medical device, and laboratory regulation",
    "Drug, alcohol, tobacco use",
    "Emergency medical services and trauma care",
    "Executive agency funding and structure",
    "Food and Drug Administration (FDA)",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Health care coverage and access",
    "Health information and medical records",
    "Health programs administration and funding",
    "Health technology, devices, supplies",
    "Infectious and parasitic diseases",
    "Medical research",
    "Mental health",
    "Minority health",
    "Neurological disorders",
    "Product development and innovation",
    "Public participation and lobbying"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-12-16",
    "date": "2023-08-04T15:15:05Z",
    "text": "Neuroscience Center of Excellence Act of 2021\n\nThis bill requires the Food and Drug Administration (FDA) to establish the Neuroscience Center of Excellence to address neuroscience diseases and disorders (e.g., addiction, Alzheimer's disease, and psychotic disorders).\n\nThe center must carry out various activities, including (1) coordinating with FDA programs that focus on certain areas, such as drug evaluation; (2) convening periodic public meetings to engage with stakeholders to address challenges associated with developing medical products for neuroscience diseases and disorders; (3) establishing a program to facilitate the collection and systemic use of patient experience data to develop such medical products; and (4) convening a public meeting to discuss how to promote equity and the inclusion of traditionally underrepresented populations in the development of such medical products.\n\nThe FDA must take actions related to these issues, such as issuing final guidance with recommendations on the collection and use of patient experience data for developing such medical products.\n\nThe Government Accountability Office must report to Congress a study that (1) reviews the participation of traditionally underrepresented populations in clinical trials for such medical products, and (2) provides recommendations for improving the participation of these populations."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Neuroscience Center of Excellence Act of 2021",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Neuroscience Center of Excellence Act of 2021",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to authorize the Secretary of Health and Human Services to establish a Neuroscience Center of Excellence.",
      "type": "official"
    }
  ],
  "updated_at": "2023-08-04T15:15:21Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s3427.xml"
}